Forecast & Rating2 analysts currently cover Genrix Bio, of which 2 give a positive rating. The average price target is ¥40.00, about 49.4% upside from the current price of ¥26.78. Coverage is limited, so the data is for reference only. Data as of May 9, 2026; this does not constitute investment advice.
May 7, 2026Price forecast
¥40.0049.37%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met15.2%
Stock price$26.78
Avg. target$40.0
High target$40
Low target$40
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.